Summit Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
SMMT on Nasdaq
Location
601 Brickell Key Drive, Suite 1000, Miami, FL

Insiders trading volume in the past year

Summit Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert W. Duggan Co-Chief Executive Officer, Director, 10%+ Owner $11B +$5.98M +0.05% Sep 10, 2025
Mahkam Zanganeh Co-Chief Executive Officer, Director, 10%+ Owner $10.9B +$5.98M +0.05% Sep 10, 2025
Manmeet Singh Soni COO and CFO, Director $70M Apr 29, 2025
Yu Xia Director $25.1M Jan 2, 2025
Jeff Huber Director $1.46M Jan 2, 2025
Ankur Dhingra Chief Financial Officer $1.33M Mar 26, 2024
Bhaskar Anand Chief Accounting Officer $689K Sep 18, 2025
Urte Gayko Director $528K Apr 25, 2022
Mostafa Ronaghi Director $321K Jan 2, 2025
Kenneth Clark Director $156K Jan 2, 2025
Ujwala Mahatme Director $116K Jan 2, 2024
Robert Booth Director $62.9K Jan 2, 2025
Alessandra Cesano Director $28.2K Jan 2, 2025
Jeffrey R. Maranian VP Corporate Controller $19.8K Dec 15, 2021

Recent Insider Transactions by Companies or Individuals for Summit Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.